Filing Details
- Accession Number:
- 0001179110-20-007166
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-10 07:55:10
- Reporting Period:
- 2020-06-09
- Accepted Time:
- 2020-06-10 07:55:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 744218 | Celldex Therapeutics Inc. | CLDX | In Vitro & In Vivo Diagnostic Substances (2835) | 133191702 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1709024 | Bates Samuel Martin | C/O Celldex Therapeutics, Inc. 53 Frontage Road Hampton NJ 08827 | Svp And Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.001 Per Share | Acquisiton | 2020-06-09 | 9,750 | $3.05 | 10,735 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Includes 985 shares of Common Stock acquired under the Company's 2004 Employee Stock Purchase Plan.
Billionaire Hedge Funds
